Chronic Fatigue Syndrome: A Systematic Review

[en] OBJECTIVE: A systematic review of the literature about chronic fatigue syndrome (CFS). METHODS: A search of the Medline database (via Ovid and PubMed) with the key words chronic fatigue syndrome, diagnosis, classification, epidemiology, etiology, physiopathology, metabolism, microbiology, immunology, virology, psychology, drug therapy, rehabilitation, and therapy. The reference lists of each article were examined for additional related articles. RESULTS: CFS was defined in 1988 by the US Centes for Disease Control and Prevention. The prevalence of chronic fatigue syndrome has ranged from 0.2% to 0.7% in the general population. In 1994, the definition of CFS was revised by Fukuda et al. Despite various research in several topics (e.g. infection, immune systems, neuroendocrinology, autonomic activity, neuromuscular involvement), the pathophysiology remains unknown. CONCLUSION: CFS, with its various major clinical and functional impacts, should be associated with a "biopsychosocial model". Progressive muscular rehabilitation, combined with behavioral and cognitive treatment, is an essential part of therapy.

Disciplines :

Orthopedics, rehabilitation & sports medicine

Author, co-author :

Maquet, Didier ; Université de Liège - ULiège > Département des sciences de la motricité > Département des sciences de la motricité

Demoulin, Christophe ; Université de Liège - ULiège > Département des sciences de la motricité > Kinésithérapie spécifique et réadaptation motrice

Crielaard, Jean-Michel ; Université de Liège - ULiège > Département des sciences de la motricité > Evaluation et entraînement des aptitudes physiques

Language :

English

Title :

Chronic Fatigue Syndrome: A Systematic Review

Publication date :

July 2006

Journal title :

Annales de Réadaptation et de Médecine Physique

ISSN :

0168-6054

Publisher :

Elsevier, Netherlands

Volume :

Issue :

Pages :

418-427

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 05 May 2009

Statistics

Number of views

98 (5 by ULiège)

Number of downloads

4 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

A new clinical entity? Leading article. Lancet 1 (1956) 789-790 [editorial]
Aaron L.A., and Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann. Intern. Med. 134 (2001) 868-881
Abbey S.E., and Garfinkel P.E. Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis. Amer. J. Psychiat. 148 (1991) 1638-1646
Abbey S.E. Somatization, illness attribution and the sociocultural psychiatry of chronic fatigue syndrome. Ciba Found. Symp. 173 (1993) 238-252
Ablashi D.V., Eastman H.B., Owen C.B., Roman M.M., Friedman J., Zabriskie J.B., et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J. Clin. Virol. 16 (2000) 179-191
Afari N., and Buchwald D. Chronic fatigue syndrome: a review. Am. J. Psychiat. 160 (2003) 221-236
Altemus M., Dale J.K., Michelson D., Demitrack M.A., Gold P.W., and Straus S.E. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Pyschoneuroendocrinology 26 (2001) 175-188
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (1994), American Psychiatric Association, Washington
Archard L.C., Bowles N.E., Behan P.O., Bell E.J., and Doyle D. Post-viral fatigue syndrome: persistence of enteroviral RNA in muscle biopsy samples. J. R. Soc. Med. 81 (1988) 326-329
Barrett-Connor E., von Muhlen D., Laughlin G.A., and Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J. Am. Geriatr. Sco. 47 (1999) 685-691
Bearn J., Allain T., Coskeran P., Munro N., Butler J., McGregor A., et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol. Psychiatry 37 (1995) 245-252
Behan P., Behan W., and Bell E. The postviral fatigue syndrome - an analysis of the findings in 50 cases. J. Infect. 10 (1985) 211-222
Behan P.O., and Hannifah H. 5-HT reuptake inhibitors in CFS. J. Immunol. Immunopharmacol. 15 (1995) 66-69
Behan P.O. Chronic fatigue syndrome as a delayed reaction to chronic lowdose organophosphate exposure. J. Nutr. Med. 6 (1996) 341-350
Bérubé L. Terminologie de neuropsychologie et de neurology du comportement (1991), Les Editions de la Chenelière Inc, Montréal
Blackwood S.K., MacHale S.M., Power M.J., Goodwin G.M., and Lawrie S.M. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J. Neurol. Neurosurg. Psychiatry 65 (1998) 541-546
Blenkiron P.M.A., Edwards R., and Lynch S. Associations between perfectionism, mood, and fatigue in chronic fatigue syndrome: a pilot study. J. Nerv. Ment. Dis. 187 (1999) 566-570
Blockmans D., Persoons P., Van Houdenhove B., Lejeune M., and Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Am. J. Med. 114 (2003) 736-741
Bou-Holaigah I., Rowe P.C., Kan J., and Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 274 (1995) 961-967
Bridges A.J. Rheumatic disorders in patients with silicone implants: a critical review. J. Biomater Sci. Polymer. Ed. 7 (1995) 147-157
Brouwers F.M., van der Werf S., Bleijenberg G., Van Der Zee L., and Van Der Meer J.W. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial. QJM 95 (2002) 677-683
Buchwald D., Cheney P.R., Peterson D.L., Henry B., Wormsley S.B., Geiger A., et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes type 6 infection. Ann. Intern. Med. 116 (1992) 103-113
Buchwald D., and Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities. Arch. Intern. Med. 154 (1994) 2049-2053
Buchwald D., Goldenberg D.L., Sullivan J.L., and Komaroff A.L. The "chronic active Epsteins-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum. 30 (1987) 1132-1136
Buchwald D., Pascualy R., Bombardier C., and Kith P. Sleep disorders in patients with chronic fatigue. Clin. Infect. Dis. 18 Suppl 1 (1994) S68-S72
Buchwald D., Sullivan J.L., and Komaroff A.L. Frequency of "chronic active Epstein- Barr virus infection" in a general medical practice. JAMA 257 (1987) 2303-2307
Buchwald D., Umali P., Umali J., Kith P., Pearlman T., and Komaroff A.L. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med. 123 (1995) 81-88
Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum. Dis. Clin. North Am. 22 (1996) 219-243
Caligiuri M., Murray C., Buchwald D., Levine H., Cheney P., Peterson D., et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J. Immunol. 139 (1987) 3306-3313
Cannon J.G., Angel J.B., Abod L.W., Vannier E., Miletto M.D., Fagioli L., et al. Interleukin-1, interleukin receptor antagonist and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J. Clin. Immunol. 17 (1997) 253-261
Choppa P.C., Vojdani A., Tagle C., Andrin R., and Magtoto L. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol. Cell. Probes 12 (1998) 301-308
Ciccone D.S., and Natelson B.H. Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom. Med. 65 (2003) 268-275
Clark M.R., and Katon W.J. The relevance of psychiatric research on somatization to the concept of chronic fatigue syndrome. In: Strauss S., et al. (Ed). Chronic fatigue syndrome (1994), Marcel Dekker, New York 329-349
Cleare A.J., Bearn J., McGregor A., McGregor A., Wessely S., Murray R.M., et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J. Affect. Disord. 35 (1995) 283-289
Cleare A.J., Blair D., Chambers S., and Wessely S. Urinary free cortisol in chronic fatigue syndrome. Am. J. Psychiatry 158 (2001) 641-643
Cleare A.J., Miell J., heap E., Sookdeo S., Young L., Malhi G.S., et al. Hypothalamopituitary- adrenal axis function in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J. Clin. Endocrinol. Metab. 86 (2001) 3545-3554
Cleare A.J., O'Keane V., and Miell J.P. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology 29 (2004) 724-732
Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocrine Abstracts 5 (2003) S35
Cope H., and David A.S. Neuroimaging in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 60 (1996) 471-473
Cox I.M., Campbell M.J., and Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 337 (1991) 757-760
De Becker P., De Meirleir K., Joos E., Campine I., Van Steenberge E., Smitz J., et al. Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm. Metab. Res. 31 (1999) 18-21
De Becker P., Dendale P., De Meirleir K., Campine I., Vandenborne K., and Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am. J. Med. 105 (1998) 22S-26S
De Lorenzo F., Hargreaves J., and Kakkar V.V. Possible relationship between chronic fatigue and postural tachycardia syndromes. Clin. Autonom. Res. 6 (1996) 263-264
De Luca J., Johnson S.K., and Natelson B.H. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis. Arch. Neurol. 50 (1993) 301-304
De Meirleir K., Bisbal C., Campine I., De Becker P., Salehzada T., Demettre E., et al. A 37 kDa A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am. J. Med. 108 (2000) 99-105
Deale A., Chalder T., Marks I., and Wessely S. Cognitive behaviour therapy for chronic fatigue syndrome: a randomized controlled trial. Am. J. Psychiatry 154 (1997) 408-414
Demitrack M., Dale J., Straus S., Laue L., Listwak S., Kruesi M., et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metabol. 73 (1991) 1224-1234
Di Luca D., Zorzenon M., Mirandola P., Colle R., Botta G.A., and Cassai E. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J. Clin. Microbiol. 33 (1995) 1660-1661
Duprez D.A., De Buyzere M.L., Drieghe B., Vanhaverbeke F., Taes Y., Michielsen W., et al. Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin. Sci. 94 (1998) 57-63
Edwards R.H.T., Gibson H., Clague J.E., and Helliwell T. Muscle histopathology and physiology in chronic fatigue syndrome. Ciba Found. Symp. 173 (1993) 102-117
Enbom M., Linde A., and Evengard B. No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J. Clin. Microbiol. 38 (2000) 2457
Evans A.C. Chronic brucellosis. JAMA 103 (1934) 665-667
Fischler B., D'Haenen H., Cluydts R., Michiels V., Demets K., Bossuyt A., et al. Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 34 (1996) 175-183
Freeman R., and Komaroff A.L. Does the chronic fatigue syndrome involve the autonomic nervous system?. Am. J. Med. 102 (1997) 357-364
Friedberg F., and Jason L.A. Chronic fatigue syndrome and fibromyalgia : clinical assessment and treatment. J. Clin. Psychol. 57 (2001) 433-455
Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Sydnrome Study Group. Ann. Intern. Med. 121 (1994) 953-959
Fulcher K.Y., and White P.D. A randomized controlled trial of graded exercise therapy in patients with the chronic fatigue syndrome. BMJ 314 (1997) 1647-1652
Gaab J., Huster D., Peisen R., Engert V., Heitz V., Schad T., et al. Hypothalamicpituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological and pharmacological stimulation. Psychosom. Med. 64 (2002) 951-962
Gatenby P.A. Silicone breast implants, where have we been and where are we now?. Aust. N. Z. J. Med. 26 (1996) 341-342
Gibson H., Carroll N., Clague J.E., and Edwards R.H.T. Exercise performance and fatiguability in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 26 (1993) 993-998
Gold D., Bowden R., Sixbey J., Riggs R., Katon W.J., Ashley R., et al. Chronic fatigue. A prospective clinical and virologic study. JAMA 264 (1990) 48-53
Goldenberg D.L., Felson D.T., and Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 29 (1986) 1371-1377
Goldenberg D.L., Simms R.W., Geiger A., and Komaroff A.L. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 33 (1990) 381-387
Goldenberg D.L. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. J. Rheumatol. 16 Suppl 19 (1989) S91-S93
Goldenberg D.L. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr. Opin. Rheumatol. 8 (1996) 113-123
Gomborone J.E., Gorard D.A., Dewsnap P.A., Libby G.W., and Farthing M.J. Prevalence of irritable bowel syndrome in chronic fatigue. J. R. Coll. Physicians Lond. 30 (1996) 512-513
Grafman J., Schwartz V., Dale J.K., Scheffers M., Houser C., and Straus S.F. Analysis of neuropsychological functioning in patients with chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 56 (1993) 684-689
Gupta S., and Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand. J. Immunol. 33 (1991) 319-327
Hamilos D.L., Nutter D., Gershtenson J., Redmond D.P., Clementi J.D., Schmaling K.B., et al. Core body temperature is normal in chronic fatigue syndrome. Biol. Pyschiatry 43 (1998) 293-302
Hay J., and Jenkins F.J. Human herpesviruses and chronic fatigue syndrome. In: Straus S.E. (Ed). Chronic fatigue syndrome (1994), Marcel Dekker, New York 181-197
Hickie I., Hadzi-Pavlovic D., and Ricci C. Reviving the diagnosis of neurasthenia. Psychol. Med. 27 (1997) 989-997
Hickie I.B., Hooker A.W., Hadzi-Pavlovic D., Bennett B.K., Wilson A.J., and Lloyd A.R. Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med. J. Aust. 164 (1996) 585-588
Hickie I.B., Wilson A.J., Murray Wright J., Bennett B.K., Wakefield D., and Lloyd A.R. A randomized, double-blind, placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J. Clin. Pyschiatry 61 (2000) 643-648
Himmel P., and Seligman T. A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J. Clin. Rheumatol. 5 (1999) 56-59
Hoffman R.E., Stehr-Green P.A., Webb K.B., Evans R.G., Knutsen A.P., Schramm W.F., et al. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-pdioxin. JAMA 255 (1986) 2031-2038
Holmes G.P., Kaplan J.E., Stewart J.A., Hunt B., Pinsky P.F., and Schonberger L.B. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause?. JAMA 257 (1987) 2297-2302
Ho-Yen D., Billington R., and Urquhart J. Natural killer cells and the post-viral fatigue syndrome. Scand. J. Infect. Dis. 23 (1991) 711-716
Hudson M., and Cleare A.J. The 1microg short Synacthen test in chronic fatigue syndrome. Clin. Endocrinol. (Oxf.) 51 (1999) 625-630
Imboden J.B., Canter A., and Cluff L.E. Convalescence from influenza: a study of the psychological and clinical determinants. Arch. Intern. Med. 108 (1961) 393-399
Isaacs R. Chronic infective mononucleosis. Blood 3 (1948) 858-861
Jaeschke R., Adachi J., Guyatt G., Keller J., and Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J. Rheumatol. 18 (1991) 447-451
Jason L.A., Richman J.A., Rademaker A.W., Jordan K.M., Plioplys A.V., Taylor R.R., et al. A community-based study of chronic fatigue syndrome. Arch. Intern. Med. 159 (1999) 2129-2137
Jason L.A., Taylor R., Wagner L., Holden J., Ferrari J.R., Plioplys A.V., et al. Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study. Am. J. Community Psychol. 23 (1995) 557-568
Johnson S.K., DeLuca J., Diamond B.J., and Natelson B.H. Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls. Percept. Mot. Skills 83 (1996) 51-62
Jones J.F., Ray C.G., Minnich L.L., Hicks M.J., Kibler R., and Lucas D.O. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann. Intern. Med. 102 (1985) 1-7
Jones J.F. Viral etiology of chronic fatigue syndrome. In: Goodnick P.J., and Klimas N.G. (Eds). Chronic fatigue and related immune deficiency syndromes (1993), American Psychiatric Press, Washington 23-43
Joyce J., Hotopf M., and Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM 90 (1997) 223-233
Kahn M.F. Le syndrome de fatigue chronique. Nouveaux développements. Rev. Rhum. 67 (2000) 483-485
Kane R.L., Gantz N.M., and Dipino R.K. Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatr. Neuropsychol. Behav. Neurol. 10 (1997) 25-31
Kent-Braun J.A., Sharma K.R., Weiner M.W., Massie B., and Miller R.G. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 43 (1993) 125-131
Kibler R., Lucas D., Hicks M., Poulos B.T., and Jones J.F. Immune function in chronic active Epstein -Barr virus infection. J. Clin. Immunol. 5 (1985) 46-54
Kirmayer L.J., and Robbins J.M. Functional somatic syndromes. In: Kirmayer L.J., and Robbins J.M. (Eds). Current concepts of somatization: research and clinical perspectives (1991), American Psychiatric Press, Washington, DC 79-106
Kitani T., Kuratsune H., Fuke I., Nakamura Y., Nakaya T., Asahi S., et al. Possible correlation between Borna disease virus infection and Japanese patients with chronic fatigue syndrome. Microbiol. Immunol. 40 (1996) 459-462
Klimas N., Salvato F., Morgan R., and Fletcher M. Immunologic abnormalities in chronic fatigue syndrome. J. Clin. Microbiol. 28 (1990) 1403-1410
Komaroff A.L. Clinical presentation of chronic fatigue syndrome (1993), Chickester (Ciba Foundation Symposium, Wiley 43-61
Kruesi M.J.P., Dale J., and Straus S.E. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J. Clin. Pyschiatry 50 (1989) 53-56
Krupp L.B., Jandorf J.L., Coyle P.K., and Mendelson W.B. Sleep disturbances in chronic fatigue syndrome. J. Psychosom. Res. 37 (1993) 325-331
Kuratsune H., Yamaguti K., Sawada M., Kodate S., Machii T., Kanakura Y., et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int. J. Mol. Med. 1 (1998) 143-146
LaManca J.J., Peckerman A., Sisto S.A., DeLuca J., Cook S., and Natelson B.H. Cardiovascular responses of women with chronic fatigue syndrome to stressful cognitive testing before and after strenuous exercise. Psychosom. Med. 63 (2001) 756-764
LaManca J.J., Sisto S.A., DeLuca J., Johnson S.K., Lange G., Pareja J., et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am. J. Med. 105 (1998) 59S-65S
Landay A.L., Jessop C., Lennette E.T., and Levy J.A. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 338 (1991) 707-712
Landro N.I., Stiles T.C., and Sletvold H. Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J. Psychosom. Res. 42 (1997) 297-306
Lange G., De Luca J., Maldjian J.A., Lee H.J., Tiersky L.A., and Natelson B.I.I. Brain MRIabnormalities exist in a subset of patients with chronic fatigue syndrome. J. Neurosci. 171 (1999) 3-7
Lawrie S.M., Manders D.N., Geddes J.R., and Pelosi A.J. A population-based incidence study of chronic fatigue. Psychol. Med. 27 (1997) 343-353
Leese G., Chattington P., Fraser W., Vora J., Edwards R., and Williams G. Short-term night shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 81 (1996) 1867-1870
Levine P.H., Whiteside T.L., Friberg D., Bryant J., Colclough G., and Herberman R.B. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin. Immunol. Immunopathol. 88 (1998) 96-104
Lewis D., Mayberg F., Fischer M., Goldberg J., Ashlon S., Graham M.M., et al. Monocygotic twins discordant for chronic fatigue syndrome; regional cerebral blood flow. SPECT Radiol. 219 (2001) 766-773
Lloyd A.R., Gandevia S.C., and Hales J.P. Muscle endurance, twitch properties, voluntary activation and perceived exertion in normal subjects and patients with chronic fatigue syndrome. Brain 114 (1991) 85-98
Lloyd A.R., Hickie I., Boughton C.R., Spencer O., and Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med. J. Aust. 153 (1990) 522-528
Lloyd A.R., Hickie I., Hickie C., and Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin. Exp. Immunol. 87 (1992) 76-79
Lloyd A.R., Hickie I., and Peterson P.K. Chronic fatigue syndrome: current concepts of pathogenesis and treatment. Curr. Clin. Top. Infect. Dis. 19 (1999) 135-159
Lloyd A.R., Hickie I., Wakefield D., Tymms K., Wakefield D., Dwyer J., et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am. J. Med. 103 (1997) 38-43
Lloyd A.R., and Pender H. The economic impact of chronic fatigue syndrome. Med. J. Aust. 157 (1992) 599-601
Lloyd A.R., Wakefield D., Dwyer J., and Boughton C. Immunologic abnormalities in the chronic fatigue syndrome. Med. J. Aust. 151 (1989) 122-124
Machale S.M., Cavanagh J.T., Bennie J., Carroll S., Goodwin G.M., and Lawrie S.M. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 38 (1998) 213-217
Magnusson A.E., Nias D.K.B., and White P.D. Is perfectionism associated with fatigue?. J. Psychosom. Res. 41 (1996) 377-383
Manu P. Chronic fatigue syndrome: the fundamentals still apply. Am. J. Med. 108 (2000) 172-173
Marcel B., Komaroff A.L., Fagioli L.R., Kornish II R.J., and Albert M.S. Cognitive deficits in patients with chronic fatigue syndrome. Biol. Psychiatry 40 (1996) 535-541
Marshall P.S., Forstot M., Callies A., Peterson P.K., and Schenck C.H. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom. Med. 59 (1997) 58-66
Marshall P.S., Watson D., Steinberg P., Cornblatt B., Peterson P.K., Callies A., et al. An assessment of cognitive function and mood in chronic fatigue syndrome. Biol. Psychiatry 39 (1996) 199-206
Mawle A.C., Nisenbaum R., Dobbins J.G., Gary Jr. H.E., Stewart J.A., Reyes M., et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J. Infect. Dis. 175 (1997) 136-141
McCully K.K., Smith S., Rajaei S., Leigh J.S., and Natelson B.H. Blood flow and muscle metabolism in chronic fatigue syndrome. Clin. Sci. (Lond.) 104 (2003) 641-647
Merikangas K., and Angst J. Neurasthenia in a longitudinal cohort study of young adults. Psychol. Med. 24 (1994) 1013-1024
Michiels V., Cluydts R., Fischler B., Hoffmann G., Le Bon O., and De Meirleir K. Cognitive functioning in patients with chronic fatigue syndrome. J. Clin. Exp. Neuropsychol. 18 (1996) 666-677
Michiels V., Cluydts R., and Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome. J. Int. Neuropsychol. Soc. 4 (1998) 456-466
Moldofsky H., and Scarisbrick P. Introduction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom. Med. 38 (1976) 35-44
Moldofsky H. Fibromyalgia, sleep disorder and chronic fatigue syndrome. Ciba Found. Symp. 173 (1993) 262-271
Moorkens G., Berwaerts J., Wynants H., and Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin. Endocrinol. (Osf) 53 (2000) 99-106
Morrison L., Behan W., and Behan P. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin. Exp. Immunol. 83 (1991) 441-446
Morriss R., Sharpe M., Sharpley A.L., Cowen P.J., Hawton K., and Morris J. Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ 306 (1993) 1161-1164
Moss-Morris R., Petrie K.J., Large R.G., and Kydd R.R. Neuropsychological deficits in chronic fatigue syndrome: artifact or reality?. J. Neurol. Neurosurg. Psychiatry 60 (1996) 474-477
Nasralla M., Haier J., and Nicolson G.L. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 18 (1999) 859-865
Natelson B.H., Cheu J., Pareja J., Ellis S.P., Policastro T., and Findley T.W. Randomised double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl.) 124 (1996) 226-230
Nisenbaum R., Jones J.F., Unger E.R., Reyes M., and Reeves W.C. A population-based. study of the clinical course of chronic fatigue syndrome. Health Qual. Life Outcomes 1 (2003) 49
Office of Population Censuses and Surveys. Living in Britain: results from the 1998 General Household Survey (2000), HMSO, London
Ojo-Amaize E., Conley E., and Peter J. Decreased natural killer cell activity is associated with severity of chronic fatigue syndrome immune dysfunction syndrome. Clin. Infect. Dis. 18 Suppl 1 (1994) S157-S159
Orbaek P., and Nise G. Neurasthenic complaints and psychometric function of toluene-exposed rotogravure printers. Am. J. Ind. Med. 16 (1989) 67-77
Ottenweller J.E., Sisto S.A., McCarty R.C., and Natelson B.H. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 43 (2001) 34-41
Parish J.G. Early outbreaks of epidemic neuromyasthenia. Postgrad. Med. J. 54 (1978) 711-717
Patnaik M., Komaroff A.L., Conley E., Ojo-Amaize E.A., and Peter J.B. Prevalence of IgM antibodies to human herpesvirus 6 (HHV-6) early antigen (P41/38) in patients with chronic fatigue syndrome. J. Infect. Dis. 172 (1995) 1364-1367 [Published erratum appears in J Infect Dis 1995; 172 : 1643]
Pawlikowska T., Chalder T., Heisch S.R., Wallace P., Wright D.J.M., and Wessely S.C. Population based study of fatigue and psychological distress. BMJ 308 (1994) 763-766
Peakman M., Deale A., Field R., Mahalingam M., and Wessely S. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin. Immunol. Immunopathol. 82 (1997) 83-91
Peterson P.K., Pheley A., Schroeppel J., Schenck C., Marshall P., Kind A., et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch. Intern. Med. 158 (1998) 908-914
Peterson P.K., Shepard J., Macres M., Schenck C., Crosson J., Rechtman D., et al. A controlled trial of intravenous immunoglobin G in chronic fatigue syndrome. Am. J. Med. 89 (1990) 554-560
Petrie K., Moss-Morriss R., and Weinman J. The impact of catastrophic beliefs on functioning in chronic fatigue syndrome. J. Psychosom. Res. 39 (1995) 31-37
Poller C., Natelson B.H., Lange G., Tiersky L., Deluca J., Policastro T., et al. Medical evaluation of Persian Gulf veterans with fatigue and/or chemical sensitivity. J. Med. 29 (1998) 101-113
Poole J., Herell R., Ashton S., Goldberg J., and Buchwald D. Results of inoproterenol tilt table resting in monozygotic twins discordant for chronic fatigue syndrome. Arch. Intern. Med. 160 (2000) 3461-3468
Powell P., Bentall R.P., Nye F.J., and Edwards R.H. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 322 (2001) 387-390
Racciatti D., Sensi S., De Remigis P., Barberio A., Sciascio T., and Pizzigallo E. Neuroendocrine aspects of chronic fatigue syndrome. Am. J. Med. 104 (1998) 1S-3S
Ramsay A.M. Epidemic neuromyasthenia. Postgrad. Med. J. 54 (1978) 718-721
Reeves W.C., Stamey F.R., Black J.B., Mawle A.C., Stewart J.A., and Pellett P.E. Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study. Clin. Infect. Dis. 31 (2000) 48-52
Reid S., Chalder T., Cleare A., Hotopf M., and Wessely S. Chronic fatigue syndrome. Clin. Evid. 8 (2002) 1075-1088
Reyes M. Chronic fatigue syndrome progression and self-defined recovery: evidence from the CDC surveillance system. JCFS 5 (1999) 17-27
Riley M.S., O'Brien C.J., McCluskey D.R., Bell N.P., and Nicholls D.P. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ 301 (1990) 953-956
Ross S., Fantie B., Straus S.F., and Grafman J. Divided attention deficits in patients with chronic fatigue syndrome. Appl. Neuropsychol. 8 (2001) 4-11
Rowe K.S. Double-blind randomised controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J. Psychiatr. Res. 31 (1997) 133-147
Rowe P.C., Bou-Holaigah I., Kan J.S., and Calkins H. Is neurally mediated hypotension an unrecognized cause of chronic fatigue?. Lancet 345 (1995) 623-624
Rowe P.C., Calkins H., DeBusk K., McKenzie R., Anand R., Sharma G., et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome. JAMA 285 (2001) 52-59
Rowe P.C., and Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am. J. Med. 105 (1998) 15S-21S
Salit B., Blomquist G., and Mitchel J.H. Response to exercise after bedrest and after training. Circulation 38 Suppl VII (1968) 1-78
Schmaling K.B., DiClementi J.B., Cullum C.M., and Jones J.F. Cognitive functioning in chronic fatigue syndrome and depression: a preliminary comparison. Psychosom. Med. 56 (1994) 383-388
Schwartz R.B., Garada B.M., Komaroff A.L., Tice H.M., Gleit M., Jolcig F.A., et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome. Nucl. Med. Commun. 13 (1992) 767-772
Scott L., Burnett F., Medback S., and Dinan T. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol. Med. 28 (1998) 285-293
Scott L., and Dinan T. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J. Affect. Disord. 47 (1998) 49-54
Scott L.V., Medbak S., and Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotrophin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr. Scand. 97 (1998) 450-457
Scott L.V., Salahuddin F., Cooney J., Svec F., and Dinan T.G. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J. Affect. Disord. 54 (1999) 129-137
Scott L.V., Svec F., and Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psych. Res. 97 (2000) 21-28
Sharpe M., Clements A., Hawton K., Young A.H., Sargent P., and Cowen P.J. Increased prolactin response to buspirone in chronic fatigue syndrome. J. Affect. Disord. 41 (1996) 71-76
Sharpe M., Hawton K., Simkin S., Surawy C., Hackmann A., Klimes I., et al. Cognitive behaviour therapy for chronic fatigue syndrome: a randomized controlled trial. BMJ 312 (1996) 22-26
Sharpe M. Chronic fatigue syndrome. Consultation-Liaison Psychiatry. Psychiatr. Clin. North Am. 19 (1996) 549-573
Sheffers M.K., Johnson R., Grafman J., Dale J.K., and Straus S.E. Attention and shortterm memory in chronic fatigue syndrome patients: an event-related potential analysis. Neurology 42 (1992) 1167-1175
Skapinakis P., Lewis G., and Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Am. J. Psychiatry 157 (2000) 1492-1498
Soetekouw P.M., Lenders J.W.M., Bleijenberg G., Thien T., and van der Meer J.W.M. Autonomic function in patients with chronic fatigue syndrome. Clin. Auton. Res. 9 (1999) 334-340
Solomon G. A clinical and laboratory profile of symptomatic women with silicone and breast implants. Semin. Arthritis Rheum. 24 (1994) 29-37
Steele L., Dobbins J.G., Fukuda K., Reyes M., Randall B., Koppelman M., et al. The epidemiology of chronic fatigue in San Francisco. Am. J. Med. 105 (1998) 83S-90S
Stewart J.M., Gewitz M.H., Weldon A., Arlievsky N., Li K., and Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 103 (1999) 116-121
Stewart J.M. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr. Res. 48 (2000) 218-226
Stokes M.J., Cooper R.G., and Edwards R.H.T. Normal muscle strength and fatiguability in patients with effort syndromes. BMJ 297 (1988) 1014-1017
Straus S., Fritz S., Dale J., Gould B., and Strober W. Lymphocyte phenotype and function in the chronic fatigue syndrome. J. Clin. Immunol. 13 (1993) 30-40
Strauss S.E., Dale J.K., Peter J.B., and Dinarello C.A. Circulating lymphokine levels in the chronic fatigue syndrome. J. Infect. Dis. 160 (1989) 1085-1086
Strickland P., Morriss R., Wearden A., and Deakin W. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J. Affect. Disord. 47 (1998) 191-194
Suhadolnik R.J., Peterson D.L., Cheng P.R., Horvath S.E., Reichenbach N.L., O'Brien K., et al. Biochemical dysregulation of the 2-5A synthelase/R Nase L antiviral defense pathway in chronic fatigue syndrome. J. Chron. Fatigue Syndrome 5 (1999) 223-242
Suhadolnik R.J., Peterson D.L., and O'Brien K. Biochemical evidence for a novel low molecular weight. A dependant Rnase L in chronic fatigue syndrome. J. Interferon Cytokine Res. 17 (1997) 377-385
Suhadolnik R.J., Reichenbach N.L., Hitzges P., Sobal R.W., Peterson D.L., Henry B., et al. Upregulation of the 2-RA syntetase/R Nase L antiviral pathway associated with chronic fatigue syndrome. Clin. Infective Dis. 18 Suppl 1 (1994) 96-104
Surawy C., Hackmann A., Hawton K., and Sharpe M. Chronic fatigue syndrome: a cognitive approach. Behav. Res. Ther. 33 (1995) 535-544
Taylor T., Dluhy R., and Williams G. β-Endorphin suppresses adrenocorticotrophin and cortisol levels in normal human subjects. J. Clin. Endocrinol. Metab. 57 (1983) 592-596
Theorell T., Blomkvist V., Lindh G., and Evengard B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom. Med. 61 (1999) 304-310
Tirelli U., Marotta G., Improta S., and Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand. J. Immunol. 40 (1994) 601-608
Van der Werf S.P., Prins J.B., Jongen P.J., van der Meer J.W., and Bleijenberg G. Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: a matched comparison between chronic fatigue syndrome and multiple sclerosis. Neuropsychiatr. Neuropsychol. Behav. Neurol. 13 (2000) 199-203
Van Houdenhove B., Neerinckx E., Onghena P., Lysens R., and Vertommen H. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia: an etiological factor of proof of good citizenship?. J. Psychosom. Res. 51 (2001) 571-576
Van Houdenhove B., Onghena P., Neerinckx E., and Hellin J. Does high "actionproneness" make people more vulnerable to chronic fatigue syndrome? A controlled psychometric study. J. Psychosom. Res. 39 (1995) 633-640
van Rensburg S.J., Potocnik F.C., Kiss T., Hugo F., van Zijl P., Mansvelt E., et al. Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res. Bull. 55 (2001) 319-325
Vasey F.B., Havice D.L., Bocanegra T.S., Seleznick M.J., Bridgeford P.H., Martinez-Osuna P., et al. Clinical findings in symptomatic women with silicone breast implants. Semin. Arthritis Rheum. 24 (1994) 22-28
Vercoulen J., Swanink C., and Zitman F. Randomised double-blind, placebocontrolled study of fluoxetine in chronic fatigue syndrome. Lancet 347 (1996) 858-861
Vernon S.D., Shukla S., and Reeves W.C. Absence of mycoplasma species DNA in chronic fatigue syndrome. J. Med. Microbiol. 52 (2003) 1027-1028
Viner R., and Christie D. Fatigue and somatic symptoms. BMJ 330 (2005) 1012-1015
Vojdani A., Choppa P.C., Tagle C., Andrin R., Samimi B., and Lapp C.W. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol. Med. Microbiol. 22 (1998) 355-365
Vojdani A., and Lapp C.W. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol. Immunotoxicol. 21 (1999) 175-202
Vollmer-Conna U., Hickie I., Hadzi-Pavlovic D., Tymms K., Wakefield D., Dwyer J., et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am. J. Med. 103 (1997) 38-43
Vollmer-Conna U., Wakefield D., Lloyd A., Hickie I., Lemon J., Bird K.D., et al. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br. J. Psychiatry 171 (1997) 377-381
Waddell G. The back pain revolution (1998), Churching Livingstone, London
Wallace II H.L., Natelson B., Gause W., et al. Human herpes viruses in chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 6 (1999) 216-223
Wearden A., and Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome (CFS). Psychol. Med. 27 (1997) 81-90
Wearden A.J., and Appleby L. Research on cognitive complaints and cognitive functioning in patients with chronic fatigue syndrome (CFS) - what conclusions can we draw?. J. Psychosom. Res. 41 (1996) 197-211
Wearden A.J., Morriss R.K., Mullis R., Strickland P.L., Pearson D.J., Appleby L., et al. Randomised, double-blind, placebo controlled treatment trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome. Br. J. Psychiatry 172 (1998) 485-490
Wessely S., Nimnuan C., and Sharpe M. Functional somatic syndromes: one or many?. Lancet 354 (1999) 936-939
Wessely S., and Powell R. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry 52 (1989) 940-948
Wessely S. Old wine in new bottles: neurasthenia and "ME". Psychol. Med. 20 (1990) 35-53
Whelton C.L., Salit I., and Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J. Rheumatol. 19 (1992) 939-943
White C., and Schweitzer R. The role of personality in the development and perpetuating of chronic fatigue syndrome. J. Psychosom. Res. 48 (2000) 515-524
White P.D. The relationship between infection and fatigue. J. Psychosom. Res. 43 (1997) 345-350
Whiteside T.L., and Friberg D.L. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am. J. Med. 105 (1998) 27-34
Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 33 (1990) 160-172
Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., et al. Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 156 (1999) 646-649
Wood B., Wessely S., Papadopoulos A., Poon L., and Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 37 (1998) 1-4
Yalcin S., Kuratsune H., Yamaguchi K., Kitani T., and Yamanishi K. Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome. Microbiol. Immunol. 38 (1994) 587-590
Yataco A., Talo H., Rowe P., Kass D.A., Berger R.D., and Calkins H. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin. Autonom. Res. 7 (1997) 293-297
Young A.H., Sharpe M., Clements A., Dowling B., Hawton K.E., and Cowen P.J. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol. Psychiatry 43 (1998) 236-237